Literature DB >> 15770053

The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.

Ali Borazan1, Selim Aydemir, Mehmet Sert, Ahmet Yilmaz.   

Abstract

OBJECTIVES: In this study, we aimed to investigate plasma homocysteine (Hcy) and serum C-reactive protein (CRP) levels in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients, and the relation among them.
MATERIALS AND METHODS: This study was carriedout on 52 HD patients, 26 CAPD patients and a control group of 22 healthy persons. Blood samples were taken from the patients for Hcy and CRP measurements.
RESULTS: Serum CRP level was found to be high in 48.1% of HD patients, 69.2% of CAPD patients and 4.5% of the healthy control group. Plasma Hcy level was found out to be above the normal limits in 73.1% of HD patients, 65.4% of CAPD patients and 9% of the healthy control group. There was a significant positive relation (r = 0.384, p < 0.001) between the levels of plasma Hcy and serum CRP in HD and CAPD patients.
CONCLUSION: The high levels of Hcy and CRP were found out to be higher in HD and CAPD patients than in the control group. In order to determine the risk rate of Hcy and CRP for coronary artery disease, extensive investigations are required in patients with chronic renal failure that also have coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15770053      PMCID: PMC1781575          DOI: 10.1080/09629350400008786

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

Review 1.  Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease.

Authors:  J W Eikelboom; G J Hankey
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-05       Impact factor: 2.894

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients.

Authors:  Beatriu Bayés; M Cruz Pastor; Jordi Bonal; Jordi Juncà; José M Hernandez; Nadal Riutort; Andreu Foraster; Ramón Romero
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

4.  Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.

Authors:  J Danesh; S Lewington
Journal:  J Cardiovasc Risk       Date:  1998-08

5.  Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.

Authors:  S H Chung; O Heimbürger; P Stenvinkel; J Bergström; B Lindholm
Journal:  Nephrol Dial Transplant       Date:  2001-11       Impact factor: 5.992

6.  Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.

Authors:  A Moustapha; A Gupta; K Robinson; K Arheart; D W Jacobsen; M J Schreiber; V W Dennis
Journal:  Kidney Int       Date:  1999-04       Impact factor: 10.612

7.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

8.  Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.

Authors:  B J Manns; E D Burgess; M E Hyndman; H G Parsons; J P Schaefer; N W Scott-Douglas
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

9.  Occurrence and significance of heart disease in uraemia. An autopsy study.

Authors:  N Clyne; L E Lins; S K Pehrsson
Journal:  Scand J Urol Nephrol       Date:  1986

10.  Dialysis-associated ischemic heart disease: insights from coronary angiography.

Authors:  S G Rostand; K A Kirk; E A Rutsky
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

View more
  4 in total

1.  Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Authors:  Taehee Kim; Elani Streja; Melissa Soohoo; Connie M Rhee; Rieko Eriguchi; Tae Woo Kim; Tae Ik Chang; Yoshitsugu Obi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2017-07-14       Impact factor: 3.754

2.  Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patients.

Authors:  Peter Yam-Kau Poon; Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

3.  Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier Donate-Correa; Violeta Cazaña-Pérez; Javier García-Pérez
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  Association between blood cadmium levels and malnutrition in peritoneal dialysis.

Authors:  Ching-Wei Hsu; Ja-Liang Lin; Dan-Tzu Lin-Tan; Wen-Hung Huang; Kuan-Hsing Chen; Tzung-Hai Yen
Journal:  BMC Nephrol       Date:  2014-01-16       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.